Biocorrx Inc. (OTCMKTS:BICX) Stock Short Interest Declines 44.3%

Posted by Teresa Graham on Oct 2nd, 2026

Biocorrx Inc. (OTCMKTS:BICX – Get Free Report) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 10,083 shares, a decrease of 44.3% from the August 31st total of 18,093 shares. Based on an average daily volume of 2,494 shares, the days-to-cover ratio is presently 4.0 days. Approximately 0.0% of the shares of the stock are short sold.

Biocorrx Stock Up 5.5%

Shares of Biocorrx stock opened at $0.21 on Friday. Biocorrx has a 12-month low of $0.15 and a 12-month high of $1.28. The stock has a market capitalization of $6.41 million, a P/E ratio of -1.77 and a beta of 0.20. The company has a 50-day simple moving average of $0.25 and a 200 day simple moving average of $0.32.

Biocorrx (OTCMKTS:BICX – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The firm had revenue of $0.09 million during the quarter, compared to analyst estimates of $0.24 million.

About Biocorrx

(Get Free Report)

BioCorRx Inc develops addiction treatment programs and related products designed to support individuals seeking recovery from alcohol and substance use disorders. The company’s offerings include the BioCorRx Recovery Program, which combines an initial detoxification protocol with counseling, behavioral support and ongoing recovery services. BioCorRx describes the program as non-addictive and designed to be delivered through qualified treatment providers.

The company also develops and markets nutritional supplements intended to support recovery and help address cravings and related wellness needs.